В В Ерохин

684 total citations
14 papers, 327 citations indexed

About

В В Ерохин is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, В В Ерохин has authored 14 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in В В Ерохин's work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). В В Ерохин is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). В В Ерохин collaborates with scholars based in Russia, United States and Estonia. В В Ерохин's co-authors include Л. Н. Черноусова, Ekaterina V. Kurbatova, Julia Ershova, Grigory Volchenkov, Boris Y. Kazennyy, Sang-Nae Cho, Kai Kliiman, Peter Cegielski, Ma Tarcela Gler and Hee Jin Kim and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and European Respiratory Journal.

In The Last Decade

В В Ерохин

13 papers receiving 317 citations

Peers

В В Ерохин
В В Ерохин
Citations per year, relative to В В Ерохин В В Ерохин (= 1×) peers Rosângela Siqueira de Oliveira

Countries citing papers authored by В В Ерохин

Since Specialization
Citations

This map shows the geographic impact of В В Ерохин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В В Ерохин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В В Ерохин more than expected).

Fields of papers citing papers by В В Ерохин

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В В Ерохин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В В Ерохин. The network helps show where В В Ерохин may publish in the future.

Co-authorship network of co-authors of В В Ерохин

This figure shows the co-authorship network connecting the top 25 collaborators of В В Ерохин. A scholar is included among the top collaborators of В В Ерохин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В В Ерохин. В В Ерохин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Стерликов, С. А., et al.. (2014). Impact of social support programme on MDR-TB patients' treatment outcomes. European Respiratory Journal. 44(Suppl 58). P2682–P2682. 1 indexed citations
2.
Risin, Semyon A., Robert L. Hunter, Boris Vishnevsky, et al.. (2014). Certain surfactants significantly enhance the activity of antibiotics in the mouse model of MTB and drug resistant MTB infection and effectively remove the bacteria from a pulmonary cavity in human ex-vivo study.. PubMed. 44(2). 117–22. 1 indexed citations
3.
Dalton, Tracy, Peter Cegielski, Somsak Akksilp, et al.. (2012). Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. The Lancet. 380(9851). 1406–1417. 163 indexed citations
4.
Kurbatova, Ekaterina V., Denise A. Kaminski, В В Ерохин, et al.. (2012). Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 32(6). 735–743. 22 indexed citations
5.
Ерохин, В В. (2012). THE ACHIEVEMENTS AND THE WAY OF INNOVATIVE DEVELOPMENT ОF PHTHISIOLOGY. Annals of the Russian academy of medical sciences. 67(11). 4–8.
6.
Kochetkov, Sergey N., et al.. (2010). New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth.. PubMed. 2(1). 108–11. 8 indexed citations
7.
Kochetkov, Sergey N., et al.. (2010). New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth. Acta Naturae. 2(1). 108–110. 1 indexed citations
8.
Vostrikov, Vitaly V., et al.. (2008). Bacteriostatic activity and decomposition products of rifampicin in aqueous solution and liposomal composition. Pharmaceutical Chemistry Journal. 42(8). 475–478. 10 indexed citations
9.
Ерохин, В В, et al.. (2003). [Current views of tuberculosis inflammation].. PubMed. 11–21. 3 indexed citations
10.
Mikhailovich, Vladimir, С. А. Лапа, Dmitry Gryadunov, et al.. (2001). Detection of Rifampicin-Resistant Mycobacterium tuberculosis Strains by Hybridization and Polymerase Chain Reaction on a Specialized TB-Microchip. Bulletin of Experimental Biology and Medicine. 131(1). 94–98. 8 indexed citations
11.
Ерохин, В В, et al.. (2001). [Critical state medicine. Surfactant therapy of adult respiratory distress syndrome (results of multicenter studies)].. PubMed. 34–8. 2 indexed citations
12.
Mikhailovich, Vladimir, С. А. Лапа, Dmitry Gryadunov, et al.. (2001). Identification of Rifampin-Resistant Mycobacterium tuberculosis Strains by Hybridization, PCR, and Ligase Detection Reaction on Oligonucleotide Microchips. Journal of Clinical Microbiology. 39(7). 2531–2540. 106 indexed citations
13.
Ерохин, В В, et al.. (1999). [Surfactant-dependent atelectasis in pulmonary tuberculosis].. PubMed. 60(5). 41–6. 1 indexed citations
14.
Ерохин, В В, et al.. (1984). [Comparison between the morphofunctional state of the thymus and peripheral organs of the immune system in tuberculosis].. PubMed. 59–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026